Protein C deficiency as the major cause of thrombophilias in childhood

Shouichi Ohga1, Akira Ishiguro, Yukihiro Takahashi

  • 1Department of Perinatal and Pediatric Medicine, Kyushu University, Fukuoka, Japan. ohgas@pediatr.med.kyushu-u.ac.jp

Insights

Inherited thrombophilias in Japanese children differ from Caucasians, with protein C deficiency being most common. Early intervention for pediatric protein C deficiency is crucial for optimal treatment.

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Thromboembolism predisposition varies by race.
  • Factor V Leiden and factor II mutations are common in Caucasians but absent in Asians.
  • Low protein S (PS), protein C (PC), and antithrombin (AT) activity are observed in Japanese adults with deep vein thrombosis.

Purpose of the Study:

  • To outline inherited thrombophilias in Japanese children.
  • To investigate the genetic basis of congenital thrombophilias in pediatric patients.
  • To inform early intervention and treatment strategies for pediatric protein C deficiency.

Main Methods:

  • Analysis of congenital thrombophilias in 48 Japanese patients under 20 years old.
  • Identification of mutations in protein S (PROS1), protein C (PROC), and antithrombin (SERPINC1) genes.
  • Comparison of genetic findings between pediatric and adult thrombophilia patients.

Main Results:

  • Protein C deficiency was the most frequent congenital thrombophilia (45%) in Japanese children, followed by PS deficiency (15%) and AT deficiency (10%).
  • Homozygous or compound heterozygous mutations in PROC were found in 50% of PC-deficient children, with PC-nagoya (1362delG) identified in half of these cases.
  • Severe neonatal complications like intracranial lesions and purpura fulminans were common in PC-deficient infants, even with non-inherited deficiency.

Conclusions:

  • Inherited thrombophilias in Japanese children have a distinct molecular epidemiology compared to Caucasians.
  • Protein C deficiency, particularly with homozygous/compound heterozygous mutations, poses significant risks in early infancy.
  • Understanding the molecular basis of pediatric thrombophilia is essential for developing targeted interventions and optimizing anticoagulant therapy.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...